Article Information
- Received March 6, 2016
- Revision received August 11, 2016
- Accepted August 13, 2016
- First published September 28, 2016.
- Version of record published September 28, 2016.
Author Information
Author contributions
Author contributions: G.A.-J., P.W.K., and J.P. designed research; I.F.A., A.R.W., and J.P. performed research; I.F.A., A.R.W., and J.P. analyzed data; I.F.A. and J.P. wrote the paper.
Disclosures
- Received March 6, 2016.
- Revision received August 11, 2016.
- Accepted August 13, 2016.
This work was supported by National Institute on Drug Abuse/National Institutes of Health Grants K01 DA038235 and P50 Pilot Grant DA015369 to J.P., R01 DA006214 to G.A.J., and R01 DA012513 to P.W.K., and the Brain and Behavior Research Foundation National Alliance for Research on Schizophrenia and Depression Grant to J.P. CNO and cocaine hydrochloride were generous gifts from the National Institute on Drug Abuse Drug Supply Program. CAV2-Cre was a generous gift from Dr. Eric Kremer at the Institut de Génétique Moléculaire de Montpellier, France. We thank Dr. Carmela Reichel for providing behavioral chambers and other resources used to conduct these experiments, and Mr. Jasper Heinsbroek for support in generating figures.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Jamie Peters, Department of Neuroscience, Medical University of South Carolina, 173 Ashley Avenue, Suite 403 BSB, Charleston, SC 29425. petersjl.upr{at}gmail.com
